Unixone Plus 1000mg/500mg Injection
Marketer
Unilex Lifesciences Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Unixone Plus 1000mg/500mg Injection
Combiflox 1000mg/500mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, halting infection spread. Administration must be solely under a physician's guidance; strict adherence to the prescribed schedule is crucial. Complete the full treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek immediate medical help for allergic reactions (rash, pruritus, edema, dyspnea). Disclose all current medications to your doctor prior to use. Pregnant or lactating individuals require prior physician consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occur. Adequate rest, a balanced diet, and ample hydration are recommended for optimal recovery. Your doctor may order laboratory and diagnostic tests to monitor treatment response.
Uses of Unixone Plus 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Unixone Plus 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Unixone Plus 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Unixone Plus 1000mg/500mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
How Unixone Plus 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Unixone Plus 1000mg/500mg Injection, offer a dual-action approach to bacterial infections. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Unixone Plus 1000mg/500mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Unixone Plus (1000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administration of Unixone Plus 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Unixone Plus 1000mg/500mg Injection may induce drowsiness, blurred vision, or dizziness. Refrain from operating vehicles if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Unixone Plus 1000mg/500mg Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
The injectable formulation of Unixone Plus (1000mg/500mg) requires careful administration in individuals with advanced hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Unixone Plus (1000mg/500mg) injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Unixone Plus 1000mg/500mg Injection :
Omitting a dose of Unixone Plus 1000mg/500mg Injection necessitates contacting your physician.
Facts to Know About Unixone Plus 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
3,018 People bought this recently